Home

FRED G WEISS

CIK 1081534 · last filed 2021-09-03

FRED G WEISS is a corporate insider who has filed 26 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $18.2K of OSMT on Sep 3, 2021. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions. 10 SEC filings were submitted jointly with Actavis plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.23M

Companies

4

Total Filings

26

Lifetime Open-Market Net

-$3.89M

Filer Profile

Reported Address
800 SCUDDERS MILL ROAD
PRINCETON, NJ 08536
Related Filers
Actavis plc — 10 joint filings, latest 2018-05-04
LAURIE SIMON HODRICK — 2 joint filings, latest 2003-08-07
JOHN M LOFFREDO — 2 joint filings, latest 2003-08-07
ROBERT A DIMELLA — 1 joint filings, latest 2003-08-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RVL Pharmaceuticals plc (OSMT) Delisted Director 118,466 $1.11 $131.5K $0 8 2021-09-03
Allergan plc (AGN) Delisted Director 29,675 — — $0 5 2018-05-04
ACT Director 24,868 $49.27 $1.23M $0 2 2015-06-08
Actavis, Inc. (WPI) Delisted Director 55,398 — — -$3.89M 8 2012-07-31

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-09-03 RVL Pharmaceuticals plc (OSMT) Delisted Tax (F) −5,506 -$18.2K EDGAR
2021-07-07 RVL Pharmaceuticals plc (OSMT) Delisted Grant (A) +61,188 $0 EDGAR
2021-06-22 RVL Pharmaceuticals plc (OSMT) Delisted Tax (F) −18,584 -$53.7K EDGAR
2021-01-26 RVL Pharmaceuticals plc (OSMT) Delisted Tax (F) −5,505 -$24.6K EDGAR
2020-05-22 RVL Pharmaceuticals plc (OSMT) Delisted Mixed +20,938 -$81.8K EDGAR
2020-01-30 RVL Pharmaceuticals plc (OSMT) Delisted Tax (F) −5,505 -$38.5K EDGAR
2019-06-19 RVL Pharmaceuticals plc (OSMT) Delisted Grant (A) +37,037 $0 EDGAR
2019-01-28 RVL Pharmaceuticals plc (OSMT) Delisted Grant (A) +34,403 $0 EDGAR
2018-05-04 Allergan plc (AGN) Delisted Grant (A) +1,985 $299.9K EDGAR
2017-05-05 Allergan plc (AGN) Delisted Mixed +555 $137.1K EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.